Status:

TERMINATED

Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Influenza A Infection

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

Neuraminidase inhibitors (NAI) are effective anti-influenza antiviral treatment. During their use in experimentally infected patients, it has been shown that the viral load detected in the nasal fluid...

Detailed Description

Study Schedule: * Patient's follow up: 7 days with 10 visits V1, V2, V3, V4, V5 every 12 hours V6, V7, V8, V9, V10 every 24 hours * V1: conducted by the GP rapid test diagnostic for influenza A, urin...

Eligibility Criteria

Inclusion

  • Influenza season declared
  • Subjects aged\>18 years and \< 65 years presenting within 36h documented of onset influenza illness
  • Who have fever \>38°C
  • Who present at least one of the following respiratory symptoms (cough, sore throat, nasal symptoms), and one of the following constitutional symptoms (headache, myalgia, sweats and or chills or fatigue)
  • Positive rapid diagnostic test for influenza A
  • Who have giving written informed consent prior to enrollment
  • Patient examined before the inclusion
  • Primary care follow up

Exclusion

  • Influenza Vaccination in the 12 months prior the beginning of the study
  • Asthma, Chronic bronchitis
  • Woman with a positive urine pregnancy test
  • Active breast feeding
  • Woman without contraception
  • Clearance of creatinine\< 30 ml/min Chronic renal disease
  • History of depression, psychiatric disorders, epilepsy
  • Patients receiving cortocosteroids, immunosuppressants or antipsychotic antiemetic drugs
  • Known oseltamivir or zanamivir hypersensibility
  • Non member of the social security or CMU

Key Trial Info

Start Date :

January 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2009

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00830323

Start Date

January 1 2009

End Date

August 1 2009

Last Update

September 30 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospices civils de Lyon

Lyon, France